E-Pet Process Video
E-Pet from Equine Partners America is a portable kit that makes the harvesting, filtration and injection of a horse’s own platelet-rich blood extremely easy and maximally effective.
Call: +1 (800) 752-8538
Equine Partners America (EqPA), formerly VetCell Americas... where our sole focus is regenerative medicine for performance horses using stem cell and platelet therapies and methodologies.
A leading distributor of VetCell, Pall (E-Pet), and Renovocyte products & services, we are dedicated to providing the most progressive stem cell and platelet treatments to assist horses’ recovery from injury and to promote optimum health. To that end, we offer a broad array of cutting edge, scientifically proven products designed to maximize equine performance and capabilities.
Equine Partners continually monitors and participates in ongoing research to stay abreast of breakthrough scientific findings that will assist us in our efforts.
In addition, we are quite proud of the professional collaboration we enjoy with partners such as RenovoCyte who are equally committed to utilizing stem cells for the promotion of equine health. These partnerships ensure that we can offer our clients comprehensive veterinary platforms for horses not found anywhere else.
If your horse sustains a tendon or ligament injury, be sure to ask your veterinary professional about Equine Partners America products. They're the natural cure.Perhaps most importantly, we are also firmly committed to distributing our products in the most direct, cost-effective and transparent manner possible. It is our pledge to those who utilize our products for the betterment of their horses.
E-Pet from Equine Partners America is a portable kit that makes the harvesting, filtration and injection of a horse’s own platelet-rich blood extremely easy and maximally effective.
MS-EQ/StemRegen is the difference between injecting an expanded stem cell population of a known, viable dose versus an unknown population of various cells. With MS-EQ/StemRegen, the total number of stem cells per dose is based on the known optimal dosing schedules and is not limited by the size of the tissue sample taken.